Electronically measured adherence to immunosuppressive medications and kidney function after deceased donor kidney transplantation

Clinical Transplantation

Volumn 25, Issue 2, 2011, Pages

  Israni, Ajay K ^a,b   Weng, Francis L ^c   Cen, Ye Ying ^a   Joffe, Marshall ^d   Kamoun, Malek ^d   Feldman, Harold I ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Saint Barnabas Health Care System   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adherence; Kidney transplant; Renal function

Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CADAVER KIDNEY; COHORT ANALYSIS; ELECTRONICS; FEMALE; GRAFT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONITOR; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AFRICAN AMERICANS; COHORT STUDIES; ELECTRONIC HEALTH RECORDS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 79953313607     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01340.x     Document Type: Article

References (24)

1. Butler JARP, Mullee M, Mason JC, Peveler RC. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 2004: 77: 769.
2. Kiley DJLC, Pollak R. A study of treatment compliance following kidney transplantation. Transplantation 1993: 55: 51.
3. Chisholm MAVL, Mulloy LL, Jagadeesan M, Wynn JJRH, Wade WE, DiPiro JT. Renal transplant patient compliance with free immunosuppressive medications. Transplantation 2000: 70: 1240.
4. Frazier PA, Davis-Ali SH, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clin Transplant 1994: 8: 550.
5. Gaston RSHS, Ward M, Jones P, Macon R. Late renal allograft loss: noncompliance masquerading as chronic rejection. Transplant Proc 1999: 31: 21.
6. Schweizer R, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S. Noncompliance in organ transplant recipients. Transplanation 1990: 49: 374.
7. Rovelli MPD, Vossler E, Bartus S, Hull D, Schweizer R. Noncompliance in renal transplant recipients: evaluation by socioeconomic groups. Transplant Proc 1989: 21: 3979.
8. Didlake RHDK, Kerman RH, Van Buren CT, Kahan BD. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc 1988: 20: 63.
9. Weng F, Israni A, Joffe M et al. Race and electronically-measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol 2005: 16: 1839.
10. De Geest S, Vanhaecke J. Methodological issues in transplant compliance research. Transplant Proc 1999: 31: 81S.
11. De Geest SAI, Dunbar-Jacob J. Measuring transplant patients' compliance with immunosuppressive therapy. West J Nurs Res 1996: 18: 595.
12. Butler JAPR, Roderick P, Horne R, Mason JC. Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation 2004: 77: 786.
13. Cramer JA. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 1995: 49: 321.
14. Feldman HIHM, Bilker W, Strom BL. Potential utility of electronic drug compliance monitoring in measures of adverse outcomes associated with immunosuppressive agents. Pharmacoepidemiol Drug Saf 1999: 8: 1.
15. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. [see comment]. Ann Inter Med 2006: 145: 247.
16. Nevins TE, Kruse L, Skeans MA, Thomas W. The natural history of azathioprine compliance after renal transplantation. Kidney Int 2001: 60: 1565.
17. De Geest S, Borgermans L, Gemoets H et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995: 59: 340.
18. Denhaerynck K, Burkhalter F, Schafer-Keller P, Steiger J, Bock A, De Geest S. Clinical consequences of non adherence to immunosuppressive medication in kidney transplant patients. Transpl Int 2009: 22: 441.
19. Vlaminck H, Maes B, Evers G et al. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004: 4: 1509.
20. Hilbrands LB, Hoitsma AJ, Koene RA. Medication compliance after renal transplantation. Transplantation 1995: 60: 914.
21. Takemoto SK, Pinsky BW, Schnitzler MA et al. A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients. Am J Transplant 2007: 7: 2704.
22. Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 2009: 9: 2597.
23. Denhaerynck K, Steiger J, Bock A et al. Prevalence and risk factors of non-adherence with immunosuppresssive medication in kidney transplant patients. Am J Transplant 2006: 7: 108.
24. Chakkera H, O'Hare A, Johansen K et al. Influence of race on kidney transplant outcomes within and outside the department of veterans affairs. J Am Soc Nephrol 2005: 16: 269.